Skip to main content
Zachary Bloomgarden, MD, Endocrinology, New York, NY, The Mount Sinai Hospital

ZacharyT.BloomgardenMD

Endocrinology New York, NY

Diabetes, Lipid Metabolism

Clinical Professor, Medicine - Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai

Dr. Bloomgarden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bloomgarden's full profile

Already have an account?

Summary

  • I am a clinician in private practice with an international reputation for writing and lecturing on diabetes, having authored more than 450 articles. I am Clinical Professor at Mount Sinai School of Medicine, and Editor of the Journal of Diabetes. I served on the Board of the American Association of Clinical Endocrinologists, the Journals Managing Subcommittee of the Endocrine Society, and the Editorial Board of Diabetes Care, and was principal investigator in numerous studies. In 2012, I was awarded the title of Master of the American College of Endocrinology. I have been listed for many years in the “Castle Connolly Guide: The Best Doctors New York Metro Area.”

    My interests span the overall field of diabetes. I have carefully followed the development of therapeutic approaches over the past two decades, and for many years wrote a renowned monthly commentary in Diabetes Care, entitled "Perspectives on the News," focusing on this and other aspects of clinical care. Currently, as the Editor of the Journal of Diabetes, I write frequent commentaries spanning various aspects of treatment. I am interested in the epidemiology of diabetes with particular focus on cardiovascular disease, and have paid particular attention to questions of cardiovascular safety and, even more important, to the potential for cardiovascular benefit of diabetes treatment. I have written on the inapplicability of current FDA recommendations for cardiovascular outcomes to the crucial questions we wish to examine in determining optimal therapeutic approaches. I also am a frequent commentator on novel treatment approaches including insulin treatment modalities, incretin-based treatments, and inhibitors of glucose transport aimed at increasing urinary glucose loss.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1977 - 1979
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1976 - 1977
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineInternship, Internal Medicine, 1974 - 1975
  • Albert Einstein College of Medicine of Yeshiva University
    Albert Einstein College of Medicine of Yeshiva UniversityClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1975 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Professor of Clinical Medicine Biocor Hospital de Doenças Cardiov, 1998
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Examining the French Paradox: Does Wine Prevent Coronary Heart Disease?  
    Bloomgarden, ZT, Primary Cardiology
  • Menopause and CHD Risk: New Perspectives.  
    Bloomgarden, ZT, Cardiovasc Reviews and Reports
  • Diabetic Nephropathy.  
    Bloomgarden, ZT, Practical Diabetology (1995, 1997)
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Can Variations in Blood Glucose be Predicted?
    Bloomgarden, ZT, An analysis of 1265 patient-days of home glucose monitoring, Diabetes
  • Brown "Serum Cholesterol in U.S. Population: Diabetics vs. Non-Diabetics, 1960-1980".
    Bloomgarden, ZT., and W.V, American Diabetes Association 23 International Research Symposium
  • Bloomgarden, Relative Risk of Insulin vs. Oral Agents: 14 Year Follow-up of Ischemic Heart Disease Mortality.
    Nagalingam, R., and ZT, Diabetes
  • Join now to see all

Other

Authored Content

  • 2019 ADA Scientific Sessions: Little Benefit of Vitamin D in Diabetes PreventionJune 2019
  • 2019 ADA Scientific Sessions: Little Benefit of Vitamin D in Diabetes PreventionJune 2019

Press Mentions

  • American Association of Clinical Endocrinologists and American College of Endocrinology 2018 Position Statement on Integration of Insulin Pumps and Continuous Glucose Monitoring in Patients with Diabetes Mellitus
    American Association of Clinical Endocrinologists and American College of Endocrinology 2018 Position Statement on Integration of Insulin Pumps and Continuous Glucose Monitoring in Patients with Diabetes MellitusMarch 18th, 2018
  • Glooko’s New Device Bluetooth-Enables Popular Glucose Meters
    Glooko’s New Device Bluetooth-Enables Popular Glucose MetersOctober 2nd, 2014
  • Taking Blood Pressure Drugs at Night May Help Prevent Type 2 Diabetes
    Taking Blood Pressure Drugs at Night May Help Prevent Type 2 DiabetesSeptember 23rd, 2015
  • Join now to see all

Committees

  • member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
  • member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
  • member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015
  • member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2021
  • member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
  • member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015

Professional Memberships

Other Languages

  • Chinese (Mandarin), French

Hospital Affiliations